B. Modan
Department of Clinical Epidemiology
Chaim Sheba Medical Center
Tel-Hashomer
Israel
Name/email consistency: high
- Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J.P., Tucker, M.A., Wacholder, S. N. Engl. J. Med. (2001)